HC Wainwright downgrades Pacira BioSciences to Neutral
HC Wainwright & Co. downgraded Pacira BioSciences to Neutral and set a $36.50 price target, roughly in line with the Oct 8 close of $36.39.
Story updates
11:44:28 AM UTC
SquawkNews
Pacira BioSciences Price Target Cut to $36.50/Share From $38.00 by HC Wainwright & Co.